Serina Therapeutics, Inc. (SER)
2.105
-0.14
(-6.44%)
USD |
NYAM |
Sep 21, 16:00
2.105
0.00 (0.00%)
After-Hours: 20:00
Serina Therapeutics Total Liabilities (Quarterly) : 7.084M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.084M |
| March 31, 2026 | 9.671M |
| December 31, 2025 | 7.159M |
| September 30, 2025 | 10.82M |
| June 30, 2025 | 7.295M |
| March 31, 2025 | 5.172M |
| September 30, 2024 | 21.26M |
| June 30, 2024 | 27.10M |
| March 31, 2024 | 15.16M |
| December 31, 2023 | 4.858M |
| September 30, 2023 | 3.897M |
| June 30, 2023 | 34.57M |
| March 31, 2023 | 32.54M |
| December 31, 2022 | 20.56M |
| September 30, 2022 | 17.16M |
| June 30, 2022 | 15.84M |
| March 31, 2022 | 14.31M |
| Date | Value |
|---|---|
| December 31, 2021 | 15.03M |
| September 30, 2021 | 12.40M |
| June 30, 2021 | 10.84M |
| March 31, 2021 | 9.263M |
| December 31, 2020 | 9.321M |
| September 30, 2020 | 7.949M |
| June 30, 2020 | 6.879M |
| March 31, 2020 | 5.467M |
| December 31, 2019 | 4.825M |
| September 30, 2019 | 3.24M |
| June 30, 2019 | 2.85M |
| March 31, 2019 | 2.294M |
| December 31, 2018 | 2.44M |
| September 30, 2018 | 1.405M |
| June 30, 2018 | 1.288M |
| March 31, 2018 | 1.661M |
| December 31, 2017 | 1.312M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Oncolytics Biotech, Inc. | 13.84M |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.873M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.81M |
| Shareholders Equity (Quarterly) | 18.73M |
| Debt to Equity Ratio | 0.1713 |
| Current Ratio | 6.653 |
| Net Debt Paydown Yield | -1.14% |